Difference between revisions of "Hereditary hemochromatosis"

From Libre Pathology
Jump to navigation Jump to search
Line 47: Line 47:
**Must be separated from ''siderosis'' -- iron in Kupffer cells.
**Must be separated from ''siderosis'' -- iron in Kupffer cells.


Grading (0-4):  
===Grading===
The quantity of iron is scored as follows:  
*0 = none.  
*0 = none.  
*1: only at high power.  
*1: only at high power.  

Revision as of 18:27, 17 January 2014

Hereditary hemochromatosis, abbreviated HH, is a genetic (autosomal dominant inherited) cause of iron deposition.

Secondary causes of hemochromatosis are dealt with in secondary hemochromatosis.

General

Epidemiology:

  • Genetic defect - HFE gene.[1]
    • One mutation (C282Y mutation) in up to 12.5% of people in populations of northern and central European origin.[2]
    • Homozygotes get the disease.[1]
  • Onset in males earlier than females (due to menses).
  • Mutation thought to confer survival advantage - several theories (increased resistance to TB, S. typhi vs. decreased iron deficiency/increased iron absorption).[2]

Associated pathology (mnemonic: hemochromatosis can cause deposits anywhere):[3][4]

Pathophysiology:

Microscopic

Features:

  • Periportal iron deposition (early).
    • Late stage disease has diffuse iron deposition.
  • Brown granular - may vaguely look like lipofuscin on H&E.

Notes:

  • Iron in the bile ducts and endothelium used to be though specific of hereditary hemochromatosis.[7]
    • It is now thought to just reflect the severity of iron deposition, i.e. if the bile ducts and endothelium have iron - it is severe.

DDx - secondary hemochromatosis:

Images

www:

Stains

Iron stain +ve -- important.

  • Light blue haze is not enough.
    • Must be separated from siderosis -- iron in Kupffer cells.

Grading

The quantity of iron is scored as follows:

  • 0 = none.
  • 1: only at high power.
  • 2: at medium power.
  • 3: at lowest power.
  • 4: seen without microscope.

Molecular

See also

References

  1. 1.0 1.1 Online 'Mendelian Inheritance in Man' (OMIM) 613609
  2. 2.0 2.1 Weinberg ED (2008). "Survival advantage of the hemochromatosis C282Y mutation". Perspect. Biol. Med. 51 (1): 98-102. doi:10.1353/pbm.2008.0001. PMID 18192769.
  3. URL: http://en.wikibooks.org/wiki/USMLE_Step_2_Review. Accessed on: 15 March 2012.
  4. Fix, OK.; Kowdley, KV. (Dec 2008). "Hereditary hemochromatosis.". Minerva Med 99 (6): 605-17. PMID 19034258.
  5. Mahon, NG.; Coonar, AS.; Jeffery, S.; Coccolo, F.; Akiyu, J.; Zal, B.; Houlston, R.; Levin, GE. et al. (Nov 2000). "Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy.". Heart 84 (5): 541-7. PMID 11040018.
  6. von Kempis, J. (Jan 2001). "Arthropathy in hereditary hemochromatosis.". Curr Opin Rheumatol 13 (1): 80-3. PMID 11148720.
  7. MG. 17 September 2009.